Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein C pseudogene 10 (HNRNPCP10) is a **pseudogene** derived from the HNRNPC gene, which encodes heterogeneous nuclear ribonucleoprotein C (C1/C2), a nuclear protein involved in mRNA processing and regulation[1][4]. As a pseudogene, HNRNPCP10 has sequence similarity to its parental protein-coding gene but typically contains mutations or truncations that prevent it from encoding a functional protein[3][5]. There is no evidence that HNRNPCP10 encodes a functional protein, nor is it recognized as a therapeutic target, receptor, enzyme, or druggable protein. Pseudogenes, in general, can act as regulatory molecules by functioning as competitive endogenous RNAs or through other RNA-mediated mechanisms, potentially influencing gene expression in health and disease[5]; however, there is no specific evidence for HNRNPCP10 playing such a role. Thus, HNRNPCP10 is not a validated therapeutic target or biomarker. Key points: - HNRNPCP10 is a **pseudogene**, not an active receptor, enzyme, or drug target. - There is **no evidence of protein product, therapeutic targeting, or specific disease association**. - Any biological significance would be through **RNA-based regulatory roles**, but no such role is known for HNRNPCP10[5]. - This entry is likely only of interest in genomic or transcriptomic annotation projects, not in drug discovery or therapeutic contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein C pseudogene 10 (HNRNPCP10).